Longfellow Investment Management CO LLC Cerevel Therapeutics Holdings, Inc. Transaction History
Longfellow Investment Management CO LLC
- $397 Million
- Q2 2024
A detailed history of Longfellow Investment Management CO LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Longfellow Investment Management CO LLC holds 1,723 shares of CERE stock, worth $0. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,723
Previous 1,337
28.87%
Holding current value
$0
Previous $56,000
25.0%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CERE
# of Institutions
270Shares Held
155MCall Options Held
2.19MPut Options Held
3.92M-
Bain Capital Investors LLC Boston, MA65.7MShares$065.37% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$012.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.54MShares$04.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.15MShares$00.01% of portfolio
-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...